Wells Fargo analyst Mohit Bansal maintained a Buy rating on Neurocrine (NBIX – Research Report) yesterday and set a price target of $180.00.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback